Distinction Between Hepatocellular Carcinoma and Hypervascular Liver Metastases in Non-cirrhotic Patients Using Gadoxetate Disodium-Enhanced Magnetic Resonance Imaging.

MLA

Ichikawa, Shintaro, et al. “Distinction Between Hepatocellular Carcinoma and Hypervascular Liver Metastases in Non-Cirrhotic Patients Using Gadoxetate Disodium-Enhanced Magnetic Resonance Imaging.” Canadian Association of Radiologists Journal = Journal l’Association Canadienne Des Radiologistes, vol. 73, no. 4, Nov. 2022, pp. 639–46. EBSCOhost, https://doi.org/10.1177/08465371221085516.

APA

Ichikawa, S., Morisaka, H., Omiya, Y., & Onishi, H. (2022). Distinction Between Hepatocellular Carcinoma and Hypervascular Liver Metastases in Non-cirrhotic Patients Using Gadoxetate Disodium-Enhanced Magnetic Resonance Imaging. Canadian Association of Radiologists Journal = Journal l’Association Canadienne Des Radiologistes, 73(4), 639–646. https://doi.org/10.1177/08465371221085516

Chicago

Ichikawa, Shintaro, Hiroyuki Morisaka, Yoshie Omiya, and Hiroshi Onishi. 2022. “Distinction Between Hepatocellular Carcinoma and Hypervascular Liver Metastases in Non-Cirrhotic Patients Using Gadoxetate Disodium-Enhanced Magnetic Resonance Imaging.” Canadian Association of Radiologists Journal = Journal l’Association Canadienne Des Radiologistes 73 (4): 639–46. doi:10.1177/08465371221085516.